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3408 | Chem. Sci., 2019, 10, 3408–341esis of 5,5-disubstituted
hydantoins by tandem a-amination and a-arylation
of silyl ketene acetals†
Rakesh K. Saunthwal, Matthew T. Cornall, Roman Abrams, John W. Ward *
and Jonathan Clayden *
5,5-Disubstituted hydantoins, formally the cyclisation products of quaternary amino acids, were formed
connectively from simple ester-derived starting materials by a one-pot tandem method. Amination of
the silyl ketene acetal derivative of a methyl ester takes place by silver-catalysed addition to the N]N
bond of an azocarboxamide, generating a N-amino-N0-aryl urea derivative of a substituted aminoester.
Treatment with a base forms an ester enolate which undergoes arylation by intramolecular migration of
an aryl ring to the a-position of the ester. The product undergoes ring closure to a hydantoin, which
may itself be deprotected and functionalised. Aryl migration is successful with rings of various electronic
character and with esters bearing functionalised and unfunctionalised chains, and the products have
features in common with several bioactive compounds.Introduction
Hydantoin rings, formally the cyclocarbonylation products of
amino acids, are found in a number of medicinally signicant
molecules (Fig. 1).1,2 For example the sodium salts of phenytoin
and fosphenytoin have anticonvulsant and antiarrhythmic
properties;3a nitrofurantoin is an antibacterial drug;3b,c niluta-
mide is an androgen receptor antagonist for the treatment of
advanced prostate cancer;4 dantrolene is used as a muscle
relaxant and to prevent malignant hyperthermia.5 Substituted
hydantoins are furthermore valuable intermediates in the
synthesis of amino acids using hydantoinases and other related
biocatalysts.6
Methods for the synthesis of substituted hydantoins7 include
the classical Urech synthesis,8 and the Bucherer–Bergs9 and
Biltz reactions.10 Milder transition metal catalysed approaches
have been reported, including the Ugi condensation,11 an ami-
nobarbituric acid-hydantoin rearrangement,12 and reactions of
activated carboxylic acids.13 Hydantoins have also been made by
a-amination of esters using copper catalysts.14,15
We have shown that intramolecular migration of an aryl ring
to the a-position of an amino acid-derived urea can provide
a general method for making substituted hydantoins16 in reac-
tions that involve intramolecular nucleophilic aromatic substi-
tution of enolates on even unactivated aromatic rings.17Cantock's Close, Bristol BS8 1TS, UK.
n@bristol.ac.uk
(ESI) available. CCDC 1867365 and
a in CIF or other electronic format see
2However, such methods make use of available amino acid
starting materials and are less applicable to the synthesis of
molecules containing ‘non-proteinogenic’ side chains. We
therefore sought to develop a tandem approach from simple
precursors in which the a-amination18 of an enolate generates
a suitable substrate for a tandem intramolecular arylation,19
leading directly to an a-arylated quaternary hydantoin.20
Our initial plan for a direct route to structurally diverse 5,5-
disubstituted hydantoins is illustrated in Scheme 1. We aimed
to initiate the hydantoin synthesis with a silver-catalysed
regioselective a-amination using an azocarboxamide to
generate a urea derivative from which N0-aryl migration to the a-
position of the resulting ester followed by ring closure would
give a hydantoin.Fig. 1 Examples of drugs containing the hydantoin motif.
This journal is © The Royal Society of Chemistry 2019
Scheme 1 A route to a-arylated quaternary hydantoins by tandem
amination-arylation of silyl ketene acetals. Z ¼ electron-withdrawing
group.
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View Article OnlineThree major challenges need to be overcome. Regioselective
addition of the silyl ketene acetal to the azocarboxamide must
lead to a 2-ureido ester to allow the subsequent aryl migration
step. Secondly, the enolate of the product must undergo rear-
rangement rather than any other alternative reaction (such as
substitution or elimination), and nally the product must
cyclise to a hydantoin. All these steps ideally should occur in
a single, tandem process.
Results and discussion
We started by exploring the amination step with a symmetrical
azodicarboxamide to allow us to study the viability of the rear-
rangement while avoiding issues of regioselectivity. Silver-
catalysed aminations of silyl ketene acetals were known using
azodicarboxylates,21 so azodicarboxamides 1 were made by
acylation of hydrazine with N-methyl-N-arylcarbamoyl chloride
followed by oxidation with NBS.22 Treatment of a mixture of the
azodicarboxamide 1a and the silyl ketene acetal 2a with AgOTf
(20 mol%) in dichloromethane gave the addition product 3 in
68% yield (Table 1, entry 1). Reducing the catalyst loading toTable 1 Optimising the amination and rearrangementa
Entry Reaction conditions
Yieldsb (%)
3 4a
1 20 mol% AgOTf, CH2Cl2, 78/ +20 C, 3 h 68 —
2 10 mol% AgOTf, THF, 78/ +20 C, 3 h 80c —
3 (1) 10 mol% AgOTf, THF, 78/ +20 C, 3 h 40 60
(2) KHMDS (2.0 equiv.), 78/ 40 C, 3 h
4 (1) 10 mol% AgOTf, THF, 78/ +20 C, 3 h 0 75
(2) KHMDS (3.0 equiv.), 78/ 40 C, 3 h
a Reactions performed using 0.34 mmol of 1a and 0.34 mmol of 2a in
3.4 ml solvent. b Isolated yield. c Similar results obtained with 15 or
20 mol% catalyst.
This journal is © The Royal Society of Chemistry 201910 mol% in THF improved this yield to 80% (entry 2). 3 carries
an N0-aryl urea function suitably located for possible aryl
transfer to an enolate derivative. We therefore added 2.0 equiv.
KHMDS to the reaction mixture in the hope of promoting this
intramolecular arylation. The rearranged product 4a was ob-
tained in 60% yield, together with 40% of intermediate 3 (entry
3). Increasing the amount of KHMDS to 3.0 equiv. gave clean
product 4a in 75% yield (entry 4).
A further series of azodicarboxamides 1b–g were made, and
likewise treated with silyl ketene acetals 2a and 2b (Scheme 2).
Hydantoin products 4b–f were formed successfully bearing
electron donating, electron withdrawing groups, and the reac-
tion was successful even with the pyridyl substituted 1g. Addi-
tionally, the structure of the p-tolyl derivative 4b was conrmed
by X-ray crystallography.23 The tandem reaction was also
successful with the more hindered silyl ketene acetal 2b derived
from 3-phenylpropionic acids, generating in one pot hydantoins
4h–j in good yields.
The products 4 all contain a pendent N-aryl urea function
derived from the second aryl substituent of the symmetricalScheme 2 Hydantoin formation from symmetrical azodicarboxamides.
Chem. Sci., 2019, 10, 3408–3412 | 3409
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View Article Onlinestarting material, and a greater atom economy would be ach-
ieved if an alternative unsymmetrical, mono-N-arylated azo-
carboxamide was used as the aminating agent. By treating N-
methyl-N-tolylcarbamoyl chloride with t-butyl carbazate, and
oxidising the product hydrazide with NBS (see ESI†), we were
able to form the azocarboxamides 5. Treating silyl ketene acetal
2a with this compound in the presence of 10 mol% AgOTf in
CH2Cl2 gave the product 6 in 76% yield, accompanied by less
than 5% of the alternative regioisomer (Table 2, entry 1). In
THF, the yield of 6 increased to 85% and the amination was fully
regioselective (entry 2).
When KHMDS was added directly to the crude reaction
mixture containing the amination product, arylation and cyc-
lisation to the N-Boc-protected aminohydantoin 7a (entries 3–5)
took place, in parallel with the results seen using the symmet-
rical aminating agent 1a. With 2.0 equiv. of KHMDS, warming
the reaction to40 C for 2 h, hydantoin product 7a was formed
in 20% yield (entry 3), increasing to 72% yield on warming to
20 C (entry 5). Other unsymmetrical aminating agents were
also explored, including N-benzoyl, N-tert-butyl-carboxamido
and N-methyl-N-tert-butyl carboxamido substituted azo
compounds. Although intermediate aminated products corre-
sponding to 6were obtained, treatment with the base led only to
decomposition.
Under these optimised reaction conditions, the generality of
the reaction was explored with various azocarboxamides 5 and
silyl ketene acetals 2 (Scheme 3). The a-amination of 2a with
a range of azocarboxamides 5 was fully regioselective in all
cases. With a simple phenyl ring, the product 7b was formed in
60% yield and its structure was conrmed by X-ray crystal
structure analysis.23 Electron withdrawing groups p-CN, m-Cl,
and m-CF3 were well tolerated, giving the products 7c–7e in 65–
71% yields. 2-Pyridyl azocarboxamide 5f likewise performed
well and gave hydantoin 7f in 50% yield.Table 2 Optimising the use of unsymmetrical aminating agentsa
Entry Reaction conditions
Yieldb (%)
6 7a
1 10 mol% AgOTf, CH2Cl2, 78/ +20 C, 2 h 76c —
2 10 mol% AgOTf, THF, 78/ +20 C, 2 h 85 —
3 (1) 10 mol% AgOTf, THF, 78/ +20 C, 2 h 40 20
(2) KHMDS (2.0 equiv.), 78/ 40 C, 2 h
4 (1) 10 mol% AgOTf, THF, 78/ +20 C, 2 h 0 50
(2) KHMDS (3.0 equiv.), 78/ 40 C, 3 h
5 (1) 10 mol% AgOTf, THF, 78/ +20 C, 2 h 0 72
(2) KHMDS (3.0 equiv.), 78/ 20 C, 2 h
a Reactions performed using 0.36 mmol of 4a, 0.36 mmol of 2a in 3.6 ml
solvent. b Isolated yield. c Similar results obtained with 15 or 20 mol%
catalyst.
Scheme 3 A general, connective synthesis of protected N-
aminohydantoins.
3410 | Chem. Sci., 2019, 10, 3408–3412A wider range of alternative silyl ketene acetal partners were
explored. 3-Phenylpropionate-derived 2b provided the hydan-
toins 7g–l by migration of either electron-donating or electron-
withdrawing rings in 51–85% yields. With a heteroaryl
migrating group, the 2-pyridyl azocarboxamide 5f provided theThis journal is © The Royal Society of Chemistry 2019
Scheme 4 Analogues of bioactive compounds containing the
hydantoin motif.
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View Article Onlinedesired product 7m in 85% yield. The more hindered 1-
naphthyl-substituted azocarboxamide 5i formed 7n in 56%
yield, and the migration of other aromatic groups substituted at
the ortho position, such as the 2-chlorophenyl group of 7p, also
gave reduced yields.
The pentanoate-derived precursor 2c likewise yielded the
hydantoins 7q–t in the presence of electron-donating, electron-
withdrawing and bulky groups, as did the benzyloxy substituted
silyl ketene acetal 2d, giving the functionalised hydantoins 7u–x
in good to excellent yields. Deprotection of 7u using 10% Pearl-
man's catalyst in MeOH24 gave 5-hydroxyethyl substituted 7y.
The potential utility of the products was demonstrated by
several transformations of the products 7, as illustrated inScheme 5 (a) Proposed mechanism of the reaction; (b) Intermediates
identiﬁed by in situ infra-red spectroscopy.
This journal is © The Royal Society of Chemistry 2019Scheme 4. Removal of the Boc protecting groups from 7i and 7j
proceeded cleanly with 20% triuoroacetic acid in CH2Cl2.
Condensation of the product N-aminohydantoins 8a and 8b
with appropriate aromatic aldehydes yielded alkylated
analogues of the muscle relaxant dantrolene (9a) and the anti-
bacterial drug nitrofurantoin (9b). Alternatively, the N–N bond
of the product could be cleaved to reveal the parent hydantoins
10. Several methods were screened for this transformation, and
we found that treatment of a selection of products 7 with
sodium nitrite in 3 : 1 acetic acid/1MHCl at 110 C (ref. 25) gave
the hydantoins 10a–c in good yield.
The course of the reaction between model substrates 5c and
2b was studied by in situ infra-red spectroscopy26,16a (see ESI† for
full details) and our proposed mechanism for the amination/
arylation cascade is presented in Scheme 5a. Silver-catalysed
regioselective addition of silyl ketene acetal 2b to the azo-
carboxamide 5c leads to the silylated addition product A,
consistent with the development of C]O stretching absorp-
tions at 1745 cm1 (ester), 1720 cm1 (carbamate) and
1678 cm1 (urea). Scheme 5b follows the course of the reaction
aer addition of KHMDS. A transforms initially into an inter-
mediate which we assign as the enolate B, consistent with the
disappearance of the ester C]O stretch at 1745 cm1, and the
appearance of peaks we assign to the enolate function at 1640–
1660 cm1 plus a peak at 1604 cm1 corresponding to the
anionic carbamate. The enolate evolves to a species that has
C]O stretching absorptions at 1764 cm1 and 1710 cm1,
typical of a hydantoin,16a and retains an anionic carbamate peak
at 1606 cm1. We assign these peaks to species D, the conjugate
base of the ultimate product 7i. The rearrangement of B to D
presumably passes through an undetectable transient inter-
mediate C that cyclises rapidly to D. Evidence from related
reactions suggests that the formation of the new C–C bond and
breakage of the old C–N bond during the formation of the
proposed intermediate C are to some extent concerted.16e,27
Conclusions
In conclusion, 5,5-disubstituted hydantoins may be formed by
a tandem amination-intramolecular arylation sequence of silyl
ketene acetals. The amination entails silver-catalysed regiose-
lective addition to the N]N bond of a new class of unsym-
metrical azocarboxamides, and the arylation takes place by
base-promoted intramolecular N to C migration within the N0-
aryl urea linkage that results from the amination step. The
hydantoin then forms directly from the product of enolate
arylation. In situ infra-red spectroscopy reveals four successive
species on the reaction pathway from the amination step to the
hydantoin ring closure. The one-pot protocol allowed the
connective synthesis of a range of 5,5-disubstituted hydantoins
bearing electronically diverse aryl substituents, compounds
which have potential applications in the construction of bio-
logically active molecules.
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